Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company focused on brain health, announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference. The event will include a fireside chat scheduled for June 12, 2024, at 2:00 p.m. ET in Miami, FL. Interested parties can view a live webcast of the presentation on Sage's Investor page. A replay will be available for 30 days post-event.

Positive

• Participation in a high-profile conference like Goldman Sachs' can boost company visibility and investor interest.
• Fireside chat format allows for in-depth discussion, potentially highlighting Sage's strategic vision and recent developments.

Negative

• The press release lacks specific details on what will be discussed, leaving potential investors with information.
• No new financial or clinical data is being presented, which may disappoint investors looking for substantive updates.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024, at 2:00 p.m. ET in Miami, FL.

A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics
Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Find out more at www.sagerx.com or engage with us on Facebook, LinkedIn, Instagram, and X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240605254101/en/

Investor Contact

Ashley Kaplowitz

786-252-1419

ashley.kaplowitz@sagerx.com

Media Contact

Matthew Henson

917-930-7147

matthew.henson@sagerx.com

Source: Sage Therapeutics, Inc.

FAQ

When is Sage Therapeutics presenting at the Goldman Sachs Healthcare Conference?

Sage Therapeutics will present on June 12, 2024, at 2:00 p.m. ET.

Where can I watch Sage Therapeutics' presentation at the Goldman Sachs Conference?

A live webcast will be available on Sage's Investor page, with a replay accessible for 30 days.

What is the stock symbol for Sage Therapeutics?

The stock symbol for Sage Therapeutics is SAGE.

What is the significance of Sage Therapeutics participating in the Goldman Sachs Healthcare Conference?

Participation in the conference can increase visibility and provide updates on the company's strategic initiatives.